Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions.
paper
Cited
Public
Unavailable
- Authors
- Blednov, Yuri A; Harris, R Adron
- Year
- 2008
- Journal
- The international journal of neuropsychopharmacology
- PMID
- 18377703
- DOI
- 10.1017/S1461145708008584
- PMCID
- PMC2574715
Recent studies have demonstrated that metabotropic glutamate receptor 5 (mGluR5) antagonists decrease alcohol self-administration and suggest that the anti-craving medication, acamprosate, may also act to decrease mGluR5 function. To address the role of mGluR5 in behavioural actions of ethanol and acamprosate, we compared mutant mice with deletion of the mGluR5 gene and mice treated with a mGluR5 antagonist (MPEP) or acamprosate. Lack of mGluR5 or administration of MPEP reduced the severity of alcohol-induced withdrawal (AW), increased the sedative effect of alcohol (duration of loss of righting reflex; LORR), and increased basal motor activity. The motor stimulation produced by ethanol was blocked by deletion of mGluR5, but not by injection of MPEP. Both acamprosate and MPEP increased ethanol-induced LORR and reduced AW. Importantly, the protective effects of both MPEP and acamprosate on AW were found when the drugs were injected before, but not after, injection of ethanol. This indicates that the drugs prevented development of dependence rather than merely producing an anticonvulsant action. No effects of acamprosate or MPEP on ethanol-induced LORR and AW were found in mGluR5 knockout mice, demonstrating that mGluR5 is required for these actions. mGluR5 null mutant mice showed decreased alcohol consumption in some, but not all, tests. These data show the importance of mGluR5 for several actions of alcohol and support the hypothesis that some effects of acamprosate require mGluR5 signalling.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Differential reductions in alcohol consumption and cue-induced alcohol-seeking behavior following mGlu5 receptor inhibition in the prelimbic vs. infralimbic subregions of the rat prefrontal cortex. | Leyrer-Jackson JM et al. | β | 2025 | β |
| Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A Pan-Steatotic Liver Disease Treatment? | Chrysavgis L et al. | β | 2025 | β |
| GPCR drug discovery: new agents, targets and indications. | Lorente JS et al. | β | 2025 | β |
| Promising strategies for the prevention of alcohol-related brain damage through optimised management of acute alcohol withdrawal: A focussed literature review. | Quelch D et al. | β | 2025 | β |
| A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder. | Celik M et al. | β | 2024 | β |
| Substance Use and Addiction. | Newton K et al. | β | 2024 | β |
| Treatment of insomnia associated with alcohol and opioid use: a narrative review. | Akinnusi M et al. | β | 2024 | β |
| Medications for treating alcohol use disorder: A narrative review. | Kranzler HR et al. | β | 2023 | β |
| Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease. | Luessen DJ et al. | β | 2022 | β |
| FACTORS CONTRIBUTING TO THE ESCALATION OF ALCOHOL CONSUMPTION. | Bowen MT et al. | β | 2022 | β |
| Negative allosteric modulation of metabotropic glutamate receptor 5 attenuates alcohol self-administration in baboons. | Salling MC et al. | β | 2021 | β |
| The Role of the Central Amygdala in Alcohol Dependence. | Roberto M et al. | β | 2021 | β |
| GPCR and Alcohol-Related Behaviors in Genetically Modified Mice. | Neasta J et al. | β | 2020 | β |
| Microglia Control Escalation of Drinking in Alcohol-Dependent Mice: Genomic and Synaptic Drivers. | Warden AS et al. | β | 2020 | β |
| Neurogranin Regulates Alcohol Sensitivity through AKT Pathway in the Nucleus Accumbens. | Nam HW et al. | β | 2020 | β |
| Recovery of Decreased Metabotropic Glutamate Receptor 5 Availability in Abstinent Alcohol-Dependent Patients. | Ceccarini J et al. | β | 2020 | β |
| Acute ethanol exposure reduces serotonin receptor 1A internalization by increasing ubiquitination and degradation of Ξ²-arrestin2. | Luessen DJ et al. | β | 2019 | β |
| GINS complex subunit 2 (GINS2) plays a protective role in alcohol-induced brain injury. | Liu C et al. | β | 2019 | β |
| Glial gene networks associated with alcohol dependence. | Erickson EK et al. | β | 2019 | β |
| Metabotropic Glutamate Receptor Subtype 5 in Alcohol-Induced Negative Affect. | Kasten CR et al. | β | 2019 | β |
| Generation of silent synapses in dentate gyrus correlates with development of alcohol addiction. | Beroun A et al. | β | 2018 | β |
| Group I Metabotropic Glutamate Receptors (mGluRs): Ins and Outs. | Mahato PK et al. | β | 2018 | β |
| Pharmacoproteomics Profile in Response to Acamprosate Treatment of an Alcoholism Animal Model. | Germany CE et al. | β | 2018 | β |
| Role of glutamatergic system and mesocorticolimbic circuits in alcohol dependence. | Alasmari F et al. | β | 2018 | β |
| Ethanol Consumption in Mice Lacking CD14, TLR2, TLR4, or MyD88. | Blednov YA et al. | β | 2017 | β |
| Glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective | Hwa L et al. | β | 2017 | β |
| Glutamate plasticity woven through the progression to alcohol use disorder: a multi-circuit perspective. | Hwa L et al. | β | 2017 | β |
| Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder. | Goodwani S et al. | β | 2017 | β |
| The Glycine Receptor-A Functionally Important Primary Brain Target of Ethanol. | SΓΆderpalm B et al. | β | 2017 | β |
| Alcohol use dependence in fragile X syndrome. | Salcedo-Arellano MJ et al. | β | 2016 | β |
| Combined Effects of Acamprosate and Escitalopram on Ethanol Consumption in Mice. | Ho AM et al. | β | 2016 | β |
| Genes and Alcohol Consumption: Studies with Mutant Mice. | Mayfield J et al. | β | 2016 | β |
| Gene Targeting Studies of Hyperexcitability and Affective States of Alcohol Withdrawal in Rodents. | Greenberg GD et al. | β | 2016 | β |
| Frequency of alcohol consumption in humans; the role of metabotropic glutamate receptors and downstream signaling pathways. | Meyers JL et al. | β | 2015 | β |
| Group 1 mGlu-family proteins promote neuroadaptation to ethanol and withdrawal-associated hippocampal damage. | Reynolds AR et al. | β | 2015 | β |
| Peroxisome proliferator-activated receptors Ξ± and Ξ³ are linked with alcohol consumption in mice and withdrawal and dependence in humans. | Blednov YA et al. | β | 2015 | β |
| Quantification of alcohol drinking patterns in mice. | Eisenhardt M et al. | β | 2015 | β |
| Brief report: Pilot single-blind placebo lead-in study of acamprosate in youth with autistic disorder. | Erickson CA et al. | β | 2014 | β |
| Exploring the role of central astrocytic glutamate uptake in ethanol reward in mice. | Smith KL et al. | β | 2014 | β |
| Impact of acamprosate on plasma amyloid-Ξ² precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker. | Erickson CA et al. | β | 2014 | β |
| Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models. | Doll CA et al. | β | 2014 | β |
| Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J mice. | Blednov YA et al. | β | 2014 | β |
| miR-339-5p inhibits alcohol-induced brain inflammation through regulating NF-ΞΊB pathway. | Zhang Y et al. | β | 2014 | β |
| Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers. | Polussa J et al. | β | 2014 | β |
| Molecular basis of alcoholism. | Most D et al. | β | 2014 | β |
| Neurotransmitters in alcoholism: A review of neurobiological and genetic studies. | Banerjee N | β | 2014 | β |
| Pharmacological approaches to reducing craving in patients with alcohol use disorders. | Haass-Koffler CL et al. | β | 2014 | β |
| Pharmacotherapy of alcohol use disorders: seventy-five years of progress. | Zindel LR et al. | β | 2014 | β |
| The clinical pharmacology of acamprosate. | Kalk NJ et al. | β | 2014 | β |
| The development of acamprosate as a treatment against alcohol relapse. | Kufahl PR et al. | β | 2014 | β |
| The mGlu5 receptor regulates extinction of cocaine-driven behaviours. | Bird MK et al. | β | 2014 | β |
| Acamprosate {monocalcium bis(3-acetamidopropane-1-sulfonate)} reduces ethanol-drinking behavior in rats and glutamate-induced toxicity in ethanol-exposed primary rat cortical neuronal cultures. | Oka M et al. | β | 2013 | β |
| Advanced transgenic approaches to understand alcohol-related phenotypes in animals. | Bilbao A | β | 2013 | β |
| GET73 increases rat extracellular hippocampal CA1 GABA levels through a possible involvement of local mGlu5 receptor. | Beggiato S et al. | β | 2013 | β |
| Glutamatergic targets for new alcohol medications. | Holmes A et al. | β | 2013 | β |
| Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome. | Erickson CA et al. | β | 2013 | β |
| mGluR1/5 receptor densities in the brains of alcoholic subjects: a whole-hemisphere autoradiography study. | Kupila J et al. | β | 2013 | β |
| New insights on neurobiological mechanisms underlying alcohol addiction. | Cui C et al. | β | 2013 | β |
| Novelty-seeking behaviors and the escalation of alcohol drinking after abstinence in mice are controlled by metabotropic glutamate receptor 5 on neurons expressing dopamine d1 receptors. | Parkitna JR et al. | β | 2013 | β |
| Pharmacotherapies for Overeating and Obesity. | Yarnell S et al. | β | 2013 | β |
| Positively correlated miRNA-mRNA regulatory networks in mouse frontal cortex during early stages of alcohol dependence. | Nunez YO et al. | β | 2013 | β |
| Behavioral actions of alcohol: phenotypic relations from multivariate analysis of mutant mouse data. | Blednov YA et al. | β | 2012 | β |
| Effects of alcohol on the membrane excitability and synaptic transmission of medium spiny neurons in the nucleus accumbens. | Marty VN et al. | β | 2012 | β |
| Glutamate transporter 1: target for the treatment of alcohol dependence. | Rao PS et al. | β | 2012 | β |
| Metabotropic glutamate receptor 5 modulates behavioral and hypothermic responses to toluene in rats. | Chan MH et al. | β | 2012 | β |
| mGlu receptors and drug addiction. | Cleva RM et al. | β | 2012 | β |
| Neuroimmune regulation of alcohol consumption: behavioral validation of genes obtained from genomic studies. | Blednov YA et al. | β | 2012 | β |
| Neuropeptide modulation of central amygdala neuroplasticity is a key mediator of alcohol dependence. | Gilpin NW et al. | β | 2012 | β |
| Nucleus accumbens mGluR5-associated signaling regulates binge alcohol drinking under drinking-in-the-dark procedures. | Cozzoli DK et al. | β | 2012 | β |
| Pharmacological management of binge eating disorder: current and emerging treatment options. | McElroy SL et al. | β | 2012 | β |
| The central amygdala and alcohol: role of Ξ³-aminobutyric acid, glutamate, and neuropeptides. | Roberto M et al. | β | 2012 | β |
| Therapeutic potential of metabotropic glutamate receptor modulators. | HovelsΓΈ N et al. | β | 2012 | β |
| Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial. | McElroy SL et al. | β | 2011 | β |
| Acamprosate-responsive brain sites for suppression of ethanol intake and preference. | Brager A et al. | β | 2011 | β |
| Accumbens Homer2-mediated signaling: a factor contributing to mouse strain differences in alcohol drinking? | Goulding SP et al. | β | 2011 | β |
| An open-label naturalistic pilot study of acamprosate in youth with autistic disorder. | Erickson CA et al. | β | 2011 | β |
| Critical thoughts on current rodent models for evaluating potential treatments of alcohol addiction and withdrawal. | Ripley TL et al. | β | 2011 | β |
| Enhanced sensitivity to attenuation of conditioned reinstatement by the mGluR 2/3 agonist LY379268 and increased functional activity of mGluR 2/3 in rats with a history of ethanol dependence. | Kufahl PR et al. | β | 2011 | β |
| Loss of ethanol conditioned taste aversion and motor stimulation in knockin mice with ethanol-insensitive Ξ±2-containing GABA(A) receptors. | Blednov YA et al. | β | 2011 | β |
| Preclinical studies of alcohol binge drinking. | Crabbe JC et al. | β | 2011 | β |
| The mGluR5 antagonist MPEP elevates accumbal dopamine and glycine levels; interaction with strychnine-sensitive glycine receptors. | Chau P et al. | β | 2011 | β |
| Brief report: acamprosate in fragile X syndrome. | Erickson CA et al. | β | 2010 | β |
| Cocaine-mediated synaptic potentiation is absent in VTA neurons from mGlu5-deficient mice. | Bird MK et al. | β | 2010 | β |
| Ghrelin receptor antagonism decreases alcohol consumption and activation of perioculomotor urocortin-containing neurons. | Kaur S et al. | β | 2010 | β |
| Metabotropic glutamate receptor 5 activity in the nucleus accumbens is required for the maintenance of ethanol self-administration in a rat genetic model of high alcohol intake. | Besheer J et al. | β | 2010 | β |
| Mice lacking Gad2 show altered behavioral effects of ethanol, flurazepam and gabaxadol. | Blednov YA et al. | β | 2010 | β |
| The metabotropic glutamate receptor subtype 5 mediates sensitivity to the sedative properties of ethanol. | Downing C et al. | β | 2010 | β |
| The nicotinic acetylcholine receptor partial agonist varenicline increases the ataxic and sedative-hypnotic effects of acute ethanol administration in C57BL/6J mice. | Kamens HM et al. | β | 2010 | β |
| Binge drinking upregulates accumbens mGluR5-Homer2-PI3K signaling: functional implications for alcoholism. | Cozzoli DK et al. | β | 2009 | β |
| Differential effects of chronic ethanol consumption and withdrawal on homer/glutamate receptor expression in subregions of the accumbens and amygdala of P rats. | Obara I et al. | β | 2009 | β |
| Metabotropic glutamate receptor ligands as potential therapeutics for addiction. | Olive MF | β | 2009 | β |
| Acute effects of acamprosate and MPEP on ethanol Drinking-in-the-Dark in male C57BL/6J mice. | Gupta T et al. | β | 2008 | β |
| How adaptation of the brain to alcohol leads to dependence: a pharmacological perspective. | Clapp P et al. | β | 2008 | β |
| Neurobiology of alcohol dependence: focus on motivational mechanisms. | Gilpin NW et al. | β | 2008 | β |